Insights On Outsourced Drug Development

1. Peptones And Vaccines: A Synergistic Approach To Enhanced Production And Efficiency 6/2/2025

   Enhance your vaccine manufacturing with peptones. Explore their benefits, analyze data-driven productivity gains, and learn integration strategies in this informative, on-demand session.

2. A Scientist's Perspective: Minimizing Hands-On Time In Molecular Assays 3/26/2026

   Autonomous digital PCR provides absolute quantification in complex matrices. Achieve five-color multiplexing and streamlined data collection without standard curves to accelerate synthetic biology.

3. Rapid Walkaway Solution For Assessing Viability In Cancer Organoids 3/31/2025

   Assess anti-cancer compounds' effects on organoid size and morphology with colorectal cancer organoids as well as discover automated imaging and viability assays to streamline drug screening and aid early identification.

4. Using SEC For Reliable Biotherapeutic Peptide Analysis 7/31/2025

   Discover a breakthrough in analytical performance that delivers unmatched precision, faster results, and reduced waste. This innovation sets a new standard for sustainable, high-resolution analysis.

5. Ushering In A New Era Of Human-Relevant Drug Discovery 7/29/2026

   With most drug candidates failing before approval, researchers need better ways to predict human responses. Gain insight into how advances in human-relevant modeling are helping improve decisions.

6. White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges 10/16/2024

   Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.

7. Tablet Manufacturing Technologies For Solid Drug Formulation 4/2/2025

   Compressed tablets are common oral solid dosages that contain the API and various excipients. Learn about the critical steps in selecting manufacturing methods and excipients to achieve the desired therapeutic effects and stability.

8. Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders: Alzheimer's Disease 10/8/2024

   Explore how genetic and environmental risk factors interact to heighten Alzheimer's disease risk, and gain insight into a novel therapeutic approach.

9. Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development 6/19/2025

   Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.

10. From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined 10/14/2025

    Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.